ICCB > Screening


Home History Personnel Publications Application Forms Small Molecule Screening RNAi Screening For Current Screeners Instrument Sign-ups Pin Transfer Request siRNA Transfection Request ICCB-L RNAi Wiki Libraries Compound Libraries RNAi Libraries Screening Information Overview and Guidelines Screening Supplies RNAi Resources Helpful Publications & Links Technology Resources Screening Facility Screening By Imaging Q-PCR Data Analysis/ Informatics General Considerations Interpretation Of Hits Available Analysis Software FAQ Screening Documents Screening Questions Building An HTS Facility Screensaver PubChem ChemBank Search

ENAMINE 1

Number of compounds	6,004
Plate Numbers	1394-1411 (18 Plates)
Concentration Information	5 mg/ml in DMSO
Plate Format	Plates 1394-1410: Columns 23-24 (empty) Click plate image to enlarge Plate 1411: Column 1 [B, D, F, H, J, L, N, P] (empty) Column 2 (empty) Column 3 [B, D, F, H, J, L, N, P] (empty) Column 4 (empty) Column 5 [B, D, F, H, I, J, K, L, M, N, O, P] (empty) Columns 6-24 (empty) Click plate image to enlarge

This collection was purchased jointly with the New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases (NERCE) and the Laboratory for Drug Discovery for Neurodegeneration (LDDN) in June 2004 . Funding was provided by NERCE and the Dana Farber/Harvard Cancer Center (DF/HCC) Cancer Drug Assays program (CDA). With the assistance of Dr. Tudor Oprea at the University of New Mexico, these compounds were specifically chosen to increase the overall diversity of the ICCB-Longwood collection, and were also selected for favorable physico-chemical properties, such as solubility, decreased toxicity, and increased stability.

Order Enamine Compounds:

ENAMINE Ltd.
23 Alexandra Matrosova Street
01103 Kiev
Ukraine
tel.: +380 44 537 32 18
fax: + 380 44 537 32 53
e-mail: enamine@enamine.net